Sodium Chloride Eye Drops (Health Solutions) – Insanitary Conditions (2019)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330
Brand
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
Lot Codes / Batch Numbers
Lot: 12022019@30, distributed between 09-01-2018 to 02-20-2019.
Products Sold
Lot: 12022019@30, distributed between 09-01-2018 to 02-20-2019.
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy is recalling SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharm due to Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
IN, OR
Page updated: Jan 7, 2026